Healthcare provider profile · identity verified

Adree Venatta, MD

Family Practice · TOLEDO, IL · NPI 1871722751

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	563	109
Amlodipine Besylate	Amlodipine Besylate	336	65
Levothyroxine Sodium	Levothyroxine Sodium	299	52
Metoprolol Succinate	Metoprolol Succinate	292	53
Lisinopril	Lisinopril	289	57
Gabapentin	Gabapentin	272	47
Losartan Potassium	Losartan Potassium	232	43
Furosemide	Furosemide	228	36
Metformin Hcl	Metformin Hcl	222	36
Albuterol Sulfate Hfa	Albuterol Sulfate	219	54
Omeprazole	Omeprazole	204	39
Hydrochlorothiazide	Hydrochlorothiazide	185	42
Meloxicam	Meloxicam	159	29
Pantoprazole Sodium	Pantoprazole Sodium	153	33
Tamsulosin Hcl	Tamsulosin Hcl	149	23
Duloxetine Hcl	Duloxetine Hcl	133	19
Metoprolol Tartrate	Metoprolol Tartrate	127	20
Montelukast Sodium	Montelukast Sodium	124	19
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	117	22
Fluticasone Propionate	Fluticasone Propionate	110	21
Pravastatin Sodium	Pravastatin Sodium	106	17
Rosuvastatin Calcium	Rosuvastatin Calcium	102	18
Fluoxetine Hcl	Fluoxetine Hcl	101	20
Potassium Chloride	Potassium Chloride	101	15
Metformin Hcl Er	Metformin Hcl	94	21
Alendronate Sodium	Alendronate Sodium	91	13
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	88	20
Trazodone Hcl	Trazodone Hcl	87	18
Pregabalin	Pregabalin	85	14
Mounjaro	Tirzepatide	82	suppressed
Sertraline Hcl	Sertraline Hcl	82	12
Carvedilol	Carvedilol	80	18
Citalopram Hbr	Citalopram Hydrobromide	79	13
Ozempic	Semaglutide	73	11
Allopurinol	Allopurinol	71	suppressed
Warfarin Sodium	Warfarin Sodium	71	11
Jardiance	Empagliflozin	70	14
Simvastatin	Simvastatin	67	13
Famotidine	Famotidine	66	15
Escitalopram Oxalate	Escitalopram Oxalate	64	suppressed
Mirtazapine	Mirtazapine	61	suppressed
Xarelto	Rivaroxaban	61	suppressed
Clopidogrel	Clopidogrel Bisulfate	59	12
Donepezil Hcl	Donepezil Hcl	59	12
Clonazepam	Clonazepam	56	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	54	suppressed
Eliquis	Apixaban	48	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	46	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	46	25
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	45	suppressed
Tramadol Hcl	Tramadol Hcl	44	13
Bupropion Xl	Bupropion Hcl	43	suppressed
Spironolactone	Spironolactone	43	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	42	suppressed
Bupropion Hcl Sr	Bupropion Hcl	42	suppressed
Diclofenac Sodium	Diclofenac Sodium	42	14
Lorazepam	Lorazepam	42	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	41	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	41	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	39	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	37	17
Naproxen	Naproxen	37	11
Oxybutynin Chloride	Oxybutynin Chloride	37	suppressed
Nystatin	Nystatin	36	11
Trulicity	Dulaglutide	36	suppressed
Atenolol	Atenolol	35	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	35	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	33	27
Buspirone Hcl	Buspirone Hcl	33	suppressed
Farxiga	Dapagliflozin Propanediol	33	suppressed
Rybelsus	Semaglutide	32	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	31	suppressed
Breo Ellipta	Fluticasone/Vilanterol	30	suppressed
Prednisone	Prednisone	30	24
Fenofibrate	Fenofibrate	29	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	29	suppressed
Lovastatin	Lovastatin	29	suppressed
Valsartan	Valsartan	29	suppressed
Colchicine	Colchicine	27	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	27	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	27	suppressed
Glipizide	Glipizide	27	suppressed
Ropinirole Hcl	Ropinirole Hcl	27	suppressed
Amiodarone Hcl	Amiodarone Hcl	26	suppressed
Synthroid	Levothyroxine Sodium	26	suppressed
Celecoxib	Celecoxib	25	suppressed
Divalproex Sodium	Divalproex Sodium	25	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	25	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	23	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	23	20
Meclizine Hcl	Meclizine Hcl	22	suppressed
Temazepam	Temazepam	22	suppressed
Alprazolam	Alprazolam	21	suppressed
Tresiba Flextouch U-200	Insulin Degludec	21	suppressed
Ezetimibe	Ezetimibe	20	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	19	16
Topiramate	Topiramate	19	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	19	suppressed
Arnuity Ellipta	Fluticasone Furoate	18	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	18	suppressed
Chlorthalidone	Chlorthalidone	18	suppressed
Entresto	Sacubitril/Valsartan	18	suppressed
Humalog Kwikpen U-100	Insulin Lispro	18	suppressed
Novolog Flexpen	Insulin Aspart	18	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	17	suppressed
Aripiprazole	Aripiprazole	17	suppressed
Baclofen	Baclofen	16	suppressed
Spiriva Respimat	Tiotropium Bromide	16	suppressed
Lansoprazole	Lansoprazole	15	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	15	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	15	suppressed
Torsemide	Torsemide	15	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	15	suppressed
Ventolin Hfa	Albuterol Sulfate	15	suppressed
Buprenorphine	Buprenorphine	14	suppressed
Labetalol Hcl	Labetalol Hcl	14	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Vascepa	Icosapent Ethyl	14	suppressed
Azelastine Hcl	Azelastine Hcl	13	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	13	suppressed
Bumetanide	Bumetanide	13	suppressed
Dutasteride	Dutasteride	13	suppressed
Irbesartan	Irbesartan	13	suppressed
Silodosin	Silodosin	13	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	12	suppressed
Azithromycin	Azithromycin	12	12
Ciprofloxacin Hcl	Ciprofloxacin Hcl	12	11
Enalapril Maleate	Enalapril Maleate	12	suppressed
Gemfibrozil	Gemfibrozil	12	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	12	suppressed
Liothyronine Sodium	Liothyronine Sodium	12	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	12	suppressed
Theophylline Er	Theophylline Anhydrous	12	suppressed
Tradjenta	Linagliptin	12	suppressed
Finasteride	Finasteride	11	suppressed
Fluconazole	Fluconazole	11	suppressed
Incruse Ellipta	Umeclidinium Bromide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error